National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

This is VAERS ID 1240408



Case Details

VAERS ID: 1240408 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Thrombocytopenia
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FURIX [FUROSEMIDE]; OXYCODONE; ENALAPRIL; VOLTAREN [DICLOFENAC SODIUM]; METFORMIN; TOUJEO; OMEPRAZOLE; INSULIN LISPRO SANOFI
Current Illness: Hypertension; Multiple sclerosis; Obesity; Pancreatic cancer metastatic (liver and spleen); Type 2 diabetes mellitus
Preexisting Conditions: Medical History/Concurrent Conditions: Skin disorder NOS
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC2021420065

Write-up: Thrombocytopenia; This is a spontaneous report from a contactable physician. This is the second of two reports. The first report is a report downloaded from a regulatory authority-WEB. The regulatory authority report number is SE-MPA-2021-026203, other case identifier is SE-VISMA-1618071388697. A 62-year-old female patient received the first dose of BNT162B2 (COMIRNATY, batch/lot number: unknown), via an unspecified route of administration on 2021 (at an unspecified age) at single dose for COVID-19 immunisation. Medical history included pancreatic cancer metastatic (liver and spleen) detected in Feb2021 and ongoing, ongoing type 2 diabetes mellitus, ongoing hypertension, ongoing obesity, ongoing multiple sclerosis, skin disease with blisters on the skin. The patient did not have any treatment for the multiple sclerosis and she had impaired liver function so she had not started any cancer treatment. Concomitant medications included furosemide (FURIX), oxycodone, enalapril, diclofenac sodium (VOLTAREN), metformin, insulin glargine (TOUJEO), omeprazole, insulin lispro (INSULIN LISPRO SANOFI). The patient experienced thrombocytopenia on 2021. The reporter stated that the thrombocytopenia started 8 days after the first dose of BNT162B2. The outcome of the event was fatal. The patient died on an unspecified date in 2021. It was unknown if an autopsy was performed. Report was assessed as serious due to death. No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.; Sender''s Comments: Linked Report(s) : SE-PFIZER INC-2021414361 the same patient/reporter, different event/dose; Reported Cause(s) of Death: Thrombocytopenia


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1240408

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166